CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,194,016 | +1489.1% | 543,200 | +1086.6% | 0.00% | – |
| Q2 2021 | $201,000 | +4925.0% | 45,777 | +5241.5% | 0.00% | – |
| Q1 2021 | $4,000 | -93.0% | 857 | -81.4% | 0.00% | – |
| Q4 2020 | $57,000 | +280.0% | 4,596 | +246.9% | 0.00% | – |
| Q3 2020 | $15,000 | -34.8% | 1,325 | -42.2% | 0.00% | – |
| Q2 2020 | $23,000 | -8.0% | 2,292 | -15.0% | 0.00% | – |
| Q4 2019 | $25,000 | +127.3% | 2,697 | +42.7% | 0.00% | – |
| Q3 2019 | $11,000 | -50.0% | 1,890 | +3.6% | 0.00% | – |
| Q2 2019 | $22,000 | +57.1% | 1,824 | +66.6% | 0.00% | – |
| Q4 2018 | $14,000 | 0.0% | 1,095 | +16.5% | 0.00% | – |
| Q3 2018 | $14,000 | -70.8% | 940 | -66.9% | 0.00% | – |
| Q2 2018 | $48,000 | +166.7% | 2,844 | +258.6% | 0.00% | – |
| Q1 2018 | $18,000 | -14.3% | 793 | 0.0% | 0.00% | – |
| Q4 2017 | $21,000 | +75.0% | 793 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | -94.5% | 793 | -96.7% | 0.00% | – |
| Q4 2016 | $217,000 | +1105.6% | 23,973 | +1383.5% | 0.00% | – |
| Q2 2016 | $18,000 | -96.0% | 1,616 | -93.3% | 0.00% | -100.0% |
| Q3 2015 | $450,000 | +22400.0% | 23,973 | +14883.1% | 0.00% | – |
| Q2 2014 | $2,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |